AB Sciex (Massachusetts, USA), Phenomenex (California, USA) and Peak Scientific (Massachusetts, USA) have announced the launch of a mobile laboratory tour across Europe.
AB Sciex (Massachusetts, USA), Phenomenex (California, USA) and Peak Scientific (Massachusetts, USA) have announced the launch of a mobile laboratory tour across Europe. The LC–MS–MS mobile laboratory will be touring throughout the first half of 2013, offering researchers looking for a separation solution to analytical challenges “open-house” opportunities.
From each company there will be a range of experts available to discuss a variety of topics ranging from drug discovery to peptide quantification. In addition, the mobile laboratory will be equipped with the latest technologies specifically designed for commonly used applications in Europe.
"Because of the sweeping changes happening in Europe, the interest in advanced LC–MS–MS solutions is expanding quickly across the continent, but not everyone can come to an AB Sciex event or a major trade show, so we are taking a next-generation laboratory to them with our European MASStastic Voyage," said Fedja Bobanovic, vice president of EMEA sales & support, AB Sciex. "We will be able to show demos, run samples, talk about the data in depth and give scientists and applied market lab personnel useful tips on how to improve their analyses."
For more information please visit:ref=http://www.absciex.com/company/news-room/ab-sciex-and-phenomenex-and-peak-scientific-take-mobile-laboratory-on-european-masstastic-voyage-tour->www.absciex.com/tour
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.